4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000229
Director sold 11,518 shares at an average $79.04 ($910,416)
- Director acquired 11,518 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
KLEIN JOSEPH III · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +11,518 | $39.94 | $460,029 | 22,532 | D |
| 2026-07-01 | Sale : show line 2 in the form 10b5-1 | −99 | $79.45 | $7,866 | 22,433 | D |
| 2026-07-01 | Sale : show line 3 in the form 10b5-1 | −11,419 | $79.04 | $902,551 | 11,014 | D |
| Open-market sales · 11,518 sh · avg $79.04 · $910,416 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −11,518 | 0 | D |
| 2026-07-01 | Grant or award : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | +5,369 | 5,369 | D |
| 2026-07-01 | Grant or award : show line 6 in the form 10b5-1 Restricted Stock Unit | +2,301 | 16,277 | D |
Loading xslF345X06/edgardoc.xml…